Center for Substance Abuse Prevention; Notice of Meeting, 1378 [2018-00369]

Download as PDF srobinson on DSK9F5VC42PROD with NOTICES 1378 Federal Register / Vol. 83, No. 8 / Thursday, January 11, 2018 / Notices Name of Committee: National Cancer Institute Special Emphasis Panel; Outstanding Investigator Award (OIA) II. Date: March 8–9, 2018. Time: 8:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Gaithersburg Marriott Washingtonian Center, 9751 Washingtonian Boulevard, Gaithersburg, MD 20878. Contact Person: Caron A. Lyman, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W126, Bethesda, MD 20892–9750, 240–276–6348, lymanc@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; SEP–9— Drug Development. Date: March 9, 2018. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 7W114, Rockville, MD 20850 (Telephone Conference Call). Contact Person: Jeffrey E. DeClue, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W114, Bethesda, MD 20892– 9750, 240–276–6371, decluej@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; TEP–1: Development of Software Tools for Post Radiation Therapy Surveillance. Date: March 13–14, 2018. Time: 4:00 p.m. to 5:00 p.m. Agenda: To review and evaluate contract proposals. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Shakeel Ahmad, Ph.D., Scientific Review Officer, Research Technology and Contract Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W102, Bethesda, MD 20892– 9750, 240–276–6349, ahmads@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Emerging Questions in Cancer Systems Biology (U01). Date: March 16, 2018. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Cancer Institute, Shady Grove, 9609 Medical Center Drive, Room 2E908, Rockville, MD 20850. Contact Person: Timothy C. Meeker, MD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W606, Bethesda, MD 20892–9750, 240–276–6464, meekert@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer VerDate Sep<11>2014 00:05 Jan 11, 2018 Jkt 244001 Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: January 5, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–00297 Filed 1–10–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention; Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given for the meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Center for Substance Abuse Prevention National Advisory Council (CSAP NAC) on February 14, 2018. The Council was established to advise the Secretary, Department of Health and Human Services (HHS); the Assistant Secretary for Mental Health and Substance Use, SAMHSA; and Director, CSAP concerning matters relating to the activities carried out by and through the Center and the policies respecting such activities. The meeting will be open to the public and will include the discussion of the substance use prevention workforce and opioid use prevention. The meeting will also include updates on CSAP program developments. The meeting will be held in Rockville, Maryland. Attendance by the public will be limited to the space available. Interested persons may present data, information, or views, orally or in writing, on issues pending before the Council. Written submissions should be forwarded to the contact person on or before one week prior to the meeting. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations should notify the contact on or before one week prior to the meeting. Five minutes maximum will be allotted for each presentation. To attend onsite, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register at the SAMHSA Committees’ website, https:// nac.samhsa.gov/Registration/ meetingsRegistration.aspx, or communicate with the CSAP Council’s PO 00000 Frm 00052 Fmt 4703 Sfmt 4703 Designated Federal Officer (see contact information below). Substantive program information may be obtained after the meeting by accessing the SAMHSA Committee website, https://nac.samhsa.gov/, or by contacting the Designated Federal Officer. Committee Name: Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Prevention National Advisory Council. Date/Time/Type: February 14, 2018, from 9:30 a.m. to 4:30 p.m. EST: (OPEN). Place: SAMHSA, 5600 Fishers Lane, Room 5A02, Rockville, MD 20852, Adobe Connect webcast: https://samhsacsap.adobeconnect.com/nac/. Contact: Matthew J. Aumen, Designated Federal Officer, SAMHSA CSAP NAC, 5600 Fishers Lane, Rockville, MD 20852, Telephone: 240–276–2440, Fax: 301–480– 8480, Email: matthew.aumen@ samhsa.hhs.gov. Carlos Castillo, Committee Management Officer, SAMHSA. [FR Doc. 2018–00369 Filed 1–10–18; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF THE INTERIOR Fish and Wildlife Service [Docket No. FWS–HQ–IA–2017–0086; FXIA16710900000–178–FF09A30000] Foreign Endangered and Threatened Species; Receipt of Permit Applications Fish and Wildlife Service, Interior. ACTION: Notice of receipt of permit applications. AGENCY: We, the U.S. Fish and Wildlife Service, invite the public to comment on applications to conduct certain activities with foreign endangered and threatened species. With some exceptions, the Endangered Species Act prohibits activities with listed species unless Federal authorization is acquired that allows such activities. The ESA also requires that we invite public comment before issuing these permits. DATES: We must receive comments by February 12, 2018. ADDRESSES: Document availability: The applications, as well as any comments and other materials that we receive, will be available for public inspection online in Docket No. FWS–HQ–IA–2017–0086 at https://www.regulations.gov. Submitting comments: You may submit comments by one of the following methods: SUMMARY: E:\FR\FM\11JAN1.SGM 11JAN1

Agencies

[Federal Register Volume 83, Number 8 (Thursday, January 11, 2018)]
[Notices]
[Page 1378]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-00369]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given for the 
meeting of the Substance Abuse and Mental Health Services 
Administration's (SAMHSA) Center for Substance Abuse Prevention 
National Advisory Council (CSAP NAC) on February 14, 2018.
    The Council was established to advise the Secretary, Department of 
Health and Human Services (HHS); the Assistant Secretary for Mental 
Health and Substance Use, SAMHSA; and Director, CSAP concerning matters 
relating to the activities carried out by and through the Center and 
the policies respecting such activities.
    The meeting will be open to the public and will include the 
discussion of the substance use prevention workforce and opioid use 
prevention. The meeting will also include updates on CSAP program 
developments.
    The meeting will be held in Rockville, Maryland. Attendance by the 
public will be limited to the space available. Interested persons may 
present data, information, or views, orally or in writing, on issues 
pending before the Council. Written submissions should be forwarded to 
the contact person on or before one week prior to the meeting. Oral 
presentations from the public will be scheduled at the conclusion of 
the meeting. Individuals interested in making oral presentations should 
notify the contact on or before one week prior to the meeting. Five 
minutes maximum will be allotted for each presentation.
    To attend onsite, submit written or brief oral comments, or request 
special accommodations for persons with disabilities, please register 
at the SAMHSA Committees' website, https://nac.samhsa.gov/Registration/meetingsRegistration.aspx, or communicate with the CSAP Council's 
Designated Federal Officer (see contact information below).
    Substantive program information may be obtained after the meeting 
by accessing the SAMHSA Committee website, https://nac.samhsa.gov/, or 
by contacting the Designated Federal Officer.

    Committee Name: Substance Abuse and Mental Health Services 
Administration, Center for Substance Abuse Prevention National 
Advisory Council.
    Date/Time/Type: February 14, 2018, from 9:30 a.m. to 4:30 p.m. 
EST: (OPEN).
    Place: SAMHSA, 5600 Fishers Lane, Room 5A02, Rockville, MD 
20852, Adobe Connect webcast: https://samhsa-csap.adobeconnect.com/nac/.
    Contact: Matthew J. Aumen, Designated Federal Officer, SAMHSA 
CSAP NAC, 5600 Fishers Lane, Rockville, MD 20852, Telephone: 240-
276-2440, Fax: 301-480-8480, Email: [email protected].

Carlos Castillo,
Committee Management Officer, SAMHSA.
[FR Doc. 2018-00369 Filed 1-10-18; 8:45 am]
BILLING CODE 4162-20-P